» Articles » PMID: 37443370

Deep Learning Model for Distinguishing Mayo Endoscopic Subscore 0 and 1 in Patients with Ulcerative Colitis

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jul 14
PMID 37443370
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to address the issue of differentiating between Mayo endoscopic subscore (MES) 0 and MES 1 using a deep learning model. A dataset of 492 ulcerative colitis (UC) patients who demonstrated MES improvement between January 2018 and December 2019 at Samsung Medical Center was utilized. Specifically, two representative images of the colon and rectum were selected from each patient, resulting in a total of 984 images for analysis. The deep learning model utilized in this study consisted of a convolutional neural network (CNN)-based encoder, with two auxiliary classifiers for the colon and rectum, as well as a final MES classifier that combined image features from both inputs. In the internal test, the model achieved an F1-score of 0.92, surpassing the performance of seven novice classifiers by an average margin of 0.11, and outperforming their consensus by 0.02. The area under the receiver operating characteristic curve (AUROC) was calculated to be 0.97 when considering MES 1 as positive, with an area under the precision-recall curve (AUPRC) of 0.98. In the external test using the Hyperkvasir dataset, the model achieved an F1-score of 0.89, AUROC of 0.86, and AUPRC of 0.97. The results demonstrate that the proposed CNN-based model, which integrates image features from both the colon and rectum, exhibits superior performance in accurately discriminating between MES 0 and MES 1 in patients with UC.

Citing Articles

Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks.

Carreras J, Roncador G, Hamoudi R Cancers (Basel). 2025; 16(24.

PMID: 39766129 PMC: 11674594. DOI: 10.3390/cancers16244230.


A hybrid approach of vision transformers and CNNs for detection of ulcerative colitis.

Shah S, Taj I, Usman S, Hassan Shah S, Imran A, Khalid S Sci Rep. 2024; 14(1):24771.

PMID: 39433818 PMC: 11494132. DOI: 10.1038/s41598-024-75901-4.


Artificial Intelligence in Coloproctology: A Review of Emerging Technologies and Clinical Applications.

Mota J, Almeida M, Martins M, Mendes F, Cardoso P, Afonso J J Clin Med. 2024; 13(19).

PMID: 39407902 PMC: 11477032. DOI: 10.3390/jcm13195842.


Capsule endoscopy and panendoscopy: A journey to the future of gastrointestinal endoscopy.

Rosa B, Cotter J World J Gastroenterol. 2024; 30(10):1270-1279.

PMID: 38596501 PMC: 11000081. DOI: 10.3748/wjg.v30.i10.1270.


Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review.

Pal P, Pooja K, Nabi Z, Gupta R, Tandan M, Rao G Indian J Gastroenterol. 2024; 43(1):172-187.

PMID: 38418774 DOI: 10.1007/s12664-024-01531-3.

References
1.
Walsh A, Matini L, Hinds C, Sexton V, Brain O, Keshav S . Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis. Intest Res. 2019; 17(3):365-374. PMC: 6667366. DOI: 10.5217/ir.2018.00173. View

2.
Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi A, Cassinotti A . Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2014; 46(11):969-73. DOI: 10.1016/j.dld.2014.07.010. View

3.
Peyrin-Biroulet L, Sandborn W, Sands B, Reinisch W, Bemelman W, Bryant R . Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol. 2015; 110(9):1324-38. DOI: 10.1038/ajg.2015.233. View

4.
Iacucci M, Parigi T, Amor R, Meseguer P, Mandelli G, Bozzola A . Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis. Gastroenterology. 2023; 164(7):1180-1188.e2. DOI: 10.1053/j.gastro.2023.02.031. View

5.
Gui X, Bazarova A, Amor R, Vieth M, De Hertogh G, Villanacci V . PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system. Gut. 2022; 71(5):889-898. PMC: 8995819. DOI: 10.1136/gutjnl-2021-326376. View